A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...

Pembrolizumab (Keytruda), an anti-PD-1 antibody, cleared minimal residual disease and protected against recurrence in patients with DNA mismatch repair-deficient (dMMR) early-stage solid cancers who ...

At the 38th Annual Meeting of the Engineering & Urology Society (EUS), Mr. Dan Luca of UCLA presented a compelling advancement in the imaging of prostate cancer (PCa), identifying prostate ductal ...